Verition Fund Management LLC 13D and 13G filings for Larimar Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:16 am Sale | 2024-09-30 | 13G | Larimar Therapeutics, Inc. LRMR | Verition Fund Management LLC | 594,067 0.900% | -2,217,064 (-78.87%) | Filing |
| 2024-02-14 08:55 am Purchase | 2023-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | Verition Fund Management LLC | 2,811,131 6.400% | 2,811,131 (New Position) | Filing |